Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc.
Plaintiff: Salix Pharmaceuticals, Inc., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd. and AlfaSigma S.p.A.
Defendant: Alvogen PB Research And Development LLC, Norwich Pharmaceticals, Inc. and Norwich Pharmaceuticals Inc.
Case Number: 1:2020cv00430
Filed: March 26, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on May 17, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 28, 2022 Opinion or Order Filing 189 ORAL ORDER: The parties are directed to meet and confer and file a joint proposed final judgment by August 3, 2022. The parties should also submit a Word version of that proposal to the Court. The parties should proceed on the assumption that the Courts conclusions will be: Norwichs ANDA will induce infringement of the asserted HE patent claims, and would induce infringement of the asserted IBS-D, and Polymorph patent claims if they were valid. Norwich has failed to show that the asserted HE claims are obvious and that they lack adequate written description. The asserted Polymorph and IBS-D claims are invalid as obvious. Ordered by Judge Richard G. Andrews on 7/28/2022. (nms)
June 16, 2022 Opinion or Order Filing 188 NOTICE of filing the following Non-Paper material(s) in multi media format: 1. Defendant's Hyperlinked Opening Post Trial Brief and Proposed Findings of Fact (D.I. 176 and 177) 2. Defendant's Hyperlinked Responsive Post Trial Brief and Proposed Findings of Fact (D.I. 183 and 184) 3. Defendant's Hyperlinked Reply Post Trial Brief (D.I. 185). Notice filed by Nathan Roger Hoeschen on behalf of Norwich Pharmaceuticals Inc. (Hoeschen, Nathan) Modified on 6/17/2022 (nms).
June 16, 2022 Opinion or Order Filing 187 Letter to The Honorable Richard G. Andrews from Cameron P. Clark regarding electronic versions of Plaintiffs post-trial briefing and findings of fact. (Clark, Cameron)
June 16, 2022 Opinion or Order CORRECTING ENTRY: The pdf for D.I. #186 has been replaced per counsel's request. Reference to certain expert testimony has been corrected. The NEF for the filing has been regenerated. (nms)
June 9, 2022 Opinion or Order Filing 186 POST-Trial Reply Brief, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen) Modified on 6/10/2022 (nms). (Main Document 186 replaced on 6/16/2022) (nms).
June 9, 2022 Opinion or Order Filing 185 REPLY Post-Trial Brief, by Norwich Pharmaceuticals Inc.. (Keller, Karen) Modified on 6/10/2022 (nms).
June 2, 2022 Opinion or Order Filing 184 Proposed Findings of Fact by Norwich Pharmaceuticals Inc.. (Keller, Karen)
June 2, 2022 Opinion or Order Filing 183 Responsive Post-Trial Brief, by Norwich Pharmaceuticals Inc.. (Keller, Karen) Modified on 6/3/2022 (nms).
June 2, 2022 Opinion or Order Filing 182 Proposed Findings of Fact by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen)
June 2, 2022 Opinion or Order Filing 181 ANSWERING Post-Trial Brief Regarding Validity, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen) Modified on 6/3/2022 (nms).
May 26, 2022 Opinion or Order CORRECTING ENTRY: The pdf for the signed order has been added to D.I. #180 as it was inadvertently omitted at the time of filing. The NEF has been regenerated. (nms)
May 12, 2022 Opinion or Order Filing 180 SO ORDERED Granting #179 Stipulation and [Proposed] Order Regarding Unasserted Claims. Signed by Judge Richard G. Andrews on 5/12/2022. (nms) (nms).
May 12, 2022 Opinion or Order Filing 179 STIPULATION and [Proposed] Order Regarding Unasserted Claims by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
April 29, 2022 Opinion or Order Filing 178 SO ORDERED Granting #173 Stipulation and Proposed Order regarding briefing schedule for Motion for Judgment of Non-Infringement. Signed by Judge Richard G. Andrews on 4/29/2022. (nms)
April 28, 2022 Opinion or Order Filing 177 Proposed Findings of Fact by Norwich Pharmaceuticals Inc.. (Keller, Karen)
April 28, 2022 Opinion or Order Filing 176 OPENING Post-Trial Brief on Invalidity, by Norwich Pharmaceuticals Inc.. (Keller, Karen) Modified on 4/29/2022 (nms).
April 28, 2022 Opinion or Order Filing 175 Proposed Findings of Fact by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen)
April 28, 2022 Opinion or Order Filing 174 OPENING Post-Trial Brief on Infringement and Secondary Considerations, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen) Modified on 4/29/2022 (nms).
April 28, 2022 Opinion or Order Filing 173 STIPULATION and [Proposed] Order Regarding Briefing Schedule for Norwich's Motion for Judgment of Non-Infringement by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
April 19, 2022 Opinion or Order CORRECTING ENTRY: The pdfs for D.I. 168, 169, 170, 171, and 172 have been replaced per the Court Reporter's request. Further corrections have been made. (nms)
April 12, 2022 Opinion or Order Filing 172 Official Transcript of Bench Trial held on 3/25/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/3/2022. Redacted Transcript Deadline set for 5/13/2022. Release of Transcript Restriction set for 7/11/2022. (Triozzi, Heather) (Main Document 172 replaced on 4/19/2022) (nms).
April 12, 2022 Opinion or Order Filing 171 Official Transcript of Bench Trial held on 3/24/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/3/2022. Redacted Transcript Deadline set for 5/13/2022. Release of Transcript Restriction set for 7/11/2022. (Triozzi, Heather) (Main Document 171 replaced on 4/19/2022) (nms).
April 12, 2022 Opinion or Order Filing 170 Official Transcript of Bench Trial held on 3/23/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/3/2022. Redacted Transcript Deadline set for 5/13/2022. Release of Transcript Restriction set for 7/11/2022. (Triozzi, Heather) (Main Document 170 replaced on 4/19/2022) (nms).
April 12, 2022 Opinion or Order Filing 169 Official Transcript of Bench Trial held on 3/22/22 before Judge Richard G. Andrews. Court Reporter Heather M.Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/3/2022. Redacted Transcript Deadline set for 5/13/2022. Release of Transcript Restriction set for 7/11/2022. (Triozzi, Heather) (Main Document 169 replaced on 4/19/2022) (nms).
April 12, 2022 Opinion or Order Filing 168 Official Transcript of Bench Trial held on 3/21/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/3/2022. Redacted Transcript Deadline set for 5/13/2022. Release of Transcript Restriction set for 7/11/2022. (Triozzi, Heather) (Main Document 168 replaced on 4/19/2022) (nms).
April 4, 2022 Opinion or Order CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's #Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. 652(b). (Taylor, Daniel)
March 31, 2022 Opinion or Order Filing 167 NOTICE of Defendant's Lodging of Trial Demonstratives by Norwich Pharmaceuticals Inc. (Attachments: #1 Exhibit 1 - 8)(Keller, Karen)
March 30, 2022 Opinion or Order Filing 166 SO ORDERED Granting #165 Stipulation and Proposed Order setting post-trial briefing schedule (see Order for details). Signed by Judge Richard G. Andrews on 3/30/2022. (nms)
March 30, 2022 Opinion or Order Filing 165 STIPULATION and [Proposed] Order on Post-Trial Briefing Schedule - by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
March 29, 2022 Opinion or Order Filing 164 NOTICE of Lodging of Plaintiffs' Trial Demonstratives by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. (Attachments: #1 Exhibits 1-8)(Clark, Cameron)
March 25, 2022 Opinion or Order Filing 163 Joint Exhibit List for Bench Trial held on 3/21/2022 - 3/25/2022. (lak) (Main Document 163 replaced on 4/8/2022) (lak).
March 25, 2022 Opinion or Order Filing 162 Witness List for Bench Trial held on 3/21/2022 - 3/25/2022. (lak)
March 25, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 5 completed on 3/25/2022. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: K. Keller. Closing arguments made. (Court Reporter Heather Triozzi.) (lak)
March 24, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 4 held on 3/24/2022. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: K. Keller. Witnesses: Dr. Michael Zaworotko, deposition of Giuseppe Viscomi, Dr. Allan Myerson. (Court Reporter Heather Triozzi.) (lak)
March 23, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 3 held on 3/23/2022. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: K. Keller. Witnesses: deposition of Dr. Mark Pimentel, Dr. Albert Harary, Dr. Philip Schoenfeld. (Court Reporter Heather Triozzi.) (lak)
March 22, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 2 held on 3/22/2022. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: K. Keller. Witnesses: Dr. Robert S. Brown, Dr. Herbert DuPont, Dr. Philip Schoenfeld, Dr. George Triadafilopulos (testified remotely), deposition of Dr. Enoch Bortey. (Court Reporter Heather Triozzi.) (lak)
March 21, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 1 held on 3/21/2022. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: K. Keller. Opening statements made. Witnesses: Dr. Robert S. Brown, Dr. Thomas Mahl, deposition of Dr. Lorin Johnson, deposition of Dr. William Forbes, Dr. Carl L. Berg, Dr. Gary Schoolnik (testified remotely). (Court Reporter Heather Triozzi.) (lak)
March 21, 2022 Opinion or Order Filing 161 Official Transcript of Pretrial Conference held on 3/4/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/11/2022. Redacted Transcript Deadline set for 4/21/2022. Release of Transcript Restriction set for 6/21/2022. (Triozzi, Heather)
March 18, 2022 Opinion or Order Pro Hac Vice Attorney Ricardo S. Camposanto for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
March 17, 2022 Opinion or Order Filing 160 Letter to Honorable Richard G. Andrews, from Cameron P. Clark, regarding copies of the requested portions of Plaintiffs expert witnesses curricula vitae in advance of trial. (Clark, Cameron) Modified on 3/17/2022 (nms).
March 15, 2022 Opinion or Order Filing 159 REDACTED VERSION of #155 Sealed Exhibits, Volume 2, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/16/2022 (nms).
March 15, 2022 Opinion or Order Filing 158 REDACTED VERSION of #149 Sealed Exhibits, Volume 1, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/16/2022 (nms).
March 15, 2022 Opinion or Order Filing 157 MOTION for Pro Hac Vice Appearance of Attorney Richardo S. Camposanto - filed by Norwich Pharmaceuticals Inc.. (Hoeschen, Nathan)
March 15, 2022 Opinion or Order SO ORDERED, re #157 MOTION for Pro Hac Vice Appearance of Attorney Richardo S. Camposanto, filed by Norwich Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 3/15/2022. (nms)
March 14, 2022 Opinion or Order SO ORDERED, re #156 STIPULATION and Proposed Order to Extend Time to file redacted filing to March 15, 2022. Signed by Judge Richard G. Andrews on 3/14/2022. (nms)
March 11, 2022 Opinion or Order Filing 156 STIPULATION and Proposed Order to Extend Time - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/14/2022 (nms).
March 11, 2022 Opinion or Order REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #149 . (nms)
March 8, 2022 Opinion or Order Filing 155 [SEALED] EXHIBITS, Volume 2 of 2 to #153 Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/9/2022 (nms).
March 8, 2022 Opinion or Order Filing 154 EXHIBITS, Volume 1 of 2 to #153 Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/9/2022 (nms).
March 8, 2022 Opinion or Order Filing 153 Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/9/2022 (nms).
March 4, 2022 Opinion or Order Filing 152 ORDER AFTER PRETRIAL CONFERENCE: The Proposed Pretrial Order is ADOPTED as modified by any discussion at the pretrial conference. Plaintiff was requested to timely submit a jointly-agreed revised pretrial order. A bench trial will begin on March 21, 2022, at 8:30 a.m. Each party should be prepared to present its case until 5:00 p.m. of each trial day, although the end of the trial day may, in the discretion of the Court, be earlier than 5:00 p.m. The trial is timed. Each side is allowed 14 hours for its opening statement and its direct and cross-examination of witnesses. Plaintiffs Motion in Limine (D.I. #150 ) is DENIED without prejudice to objections at trial and to post trial briefing on any preserved objections. Signed by Judge Richard G. Andrews on 3/4/2022. (nms)
March 4, 2022 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 3/4/2022. Counsel for Plaintiffs: C. Clark. Counsel for Defendant: N. Hoeschen. The parties are directed to submit a joint revised pretrial order by early next week. A few days before the start of the trial, the parties are directed to provide the Court with binders of the witnesses they intend to call. (Court Reporter Heather Triozzi.) (lak)
February 28, 2022 Opinion or Order Filing 151 EXHIBITS to #150 MOTION in Limine #1, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/1/2022 (nms).
February 28, 2022 Opinion or Order Filing 150 MOTION in Limine #1 - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/1/2022 (nms).
February 28, 2022 Opinion or Order Filing 149 [SEALED] EXHIBIT, Volume 2 of 2 to #147 Joint Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/1/2022 (nms).
February 28, 2022 Opinion or Order Filing 148 EXHIBITS, Volume 1 of 2 to #147 Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/1/2022 (nms).
February 28, 2022 Opinion or Order Filing 147 Joint Proposed Pretrial Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/1/2022 (nms).
February 18, 2022 Opinion or Order Filing 146 NOTICE OF SERVICE of Defendant's Notice Pursuant to 35 U.S.C 282 filed by Norwich Pharmaceuticals Inc..(Hoeschen, Nathan)
February 10, 2022 Opinion or Order Pro Hac Vice Attorney Aziz Burgy for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
February 9, 2022 Opinion or Order Filing 145 MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy - filed by Norwich Pharmaceuticals Inc.. (Keller, Karen)
February 9, 2022 Opinion or Order SO ORDERED, re #145 MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy, filed by Norwich Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 2/9/2022. (nms)
January 11, 2022 Opinion or Order Filing 144 NOTICE OF SERVICE of Prior art-based invalidity positions, prior art references and non-prior art invalidity positions pursuant to Paragraph 3(g)(iv) of the Scheduling Order (D.I. 23) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
December 22, 2021 Opinion or Order Filing 143 NOTICE OF SERVICE of Plaintiffs' Third Set of Narrowed Asserted Claims filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Jacobs, Karen)
December 17, 2021 Opinion or Order Filing 142 STIPULATION TO EXTEND TIME various documents to various dates (see Stipulation) - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
December 17, 2021 Opinion or Order SO ORDERED, re #142 STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 12/17/2021. (nms)
November 9, 2021 Opinion or Order Filing 141 NOTICE requesting Clerk to remove David M. Fry as co-counsel.. (Keller, Karen)
November 5, 2021 Opinion or Order Filing 140 NOTICE OF SERVICE of Reply Expert Report of David Taft, Ph.D. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
October 20, 2021 Opinion or Order Filing 139 NOTICE OF SERVICE of (1) Reply Expert Report of Philip Schoenfeld, M.D., (2) Reply Expert Report of Roberts S. Brown Jr., M.D., M.P.H., and (3) Reply Expert Report of Allan S. Myerson, Ph.D. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
October 19, 2021 Opinion or Order Filing 138 NOTICE OF SERVICE of (1) Reply Report of Carl L. Berg, M.D. (2) Reply Expert Report of Michael J. Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3) Expert Report of Deforest McDuff, Ph.D. (4) Reply Expert Report of Gary K. Schoolnik, M.D. (5) Reply Expert Report of Albert Harary, M.D. Regarding Invalidity (6) Reply Expert Report of Richard F. Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard F. Bergstrom, Ph.D. Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
October 14, 2021 Opinion or Order Filing 137 MOTION for Pro Hac Vice Appearance of Attorney Damien N. Dombrowski - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
October 14, 2021 Opinion or Order SO ORDERED, re #137 MOTION for Pro Hac Vice Appearance of Attorney Damien N. Dombrowski, filed by Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., AlfaSigma S.p.A.. Signed by Judge Richard G. Andrews on 10/14/2021. (nms)
October 11, 2021 Opinion or Order Filing 136 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Defendant's Interrogatory No. 17 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
September 28, 2021 Opinion or Order Filing 135 NOTICE OF SERVICE of 1. Expert Report of George Triadafilopoulos, M.D. 2. Rebuttal Expert Report of Michael J. Zaworotko, Ph.D. Regarding Noninfringement 3. Expert Report of Thomas C. Mahl, M.D. filed by Norwich Pharmaceuticals Inc..(Fry, David)
September 27, 2021 Opinion or Order Filing 134 STIPULATION and Order to Extend Expert Report Deadlines, by Norwich Pharmaceuticals Inc.. (Fry, David) Modified on 9/27/2021 (nms).
September 27, 2021 Opinion or Order Filing 133 Official Transcript of Discovery Dispute Videoconference held on 9/3/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/18/2021. Redacted Transcript Deadline set for 10/28/2021. Release of Transcript Restriction set for 12/27/2021. (Triozzi, Heather)
September 27, 2021 Opinion or Order SO ORDERED, re #134 Stipulation and Order to Extend Time. Signed by Judge Richard G. Andrews on 9/27/2021. (nms)
September 24, 2021 Opinion or Order Filing 132 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendant's Fourth Set of Interrogatories (Nos. 17-19) and (2) Plaintiffs' Responses and Objections to Defendant's Third Set of Requests for Production (Nos. 55-63) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
September 17, 2021 Opinion or Order Filing 131 REDACTED VERSION of #125 Letter by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit A-F)(Clark, Cameron)
September 10, 2021 Opinion or Order Filing 130 STIPULATION TO EXTEND TIME for Plaintiffs to file public versions of its Letter Brief in opposition to Defendants Motion to Strike and supporting documents (D.I. 125) to September 17, 2021 - filed by Norwich Pharmaceuticals Inc.. (Fry, David)
September 10, 2021 Opinion or Order SO ORDERED, re #130 STIPULATION TO EXTEND TIME to file public versions of Letter (D.I. #125 ) to September 17, 2021. Signed by Judge Richard G. Andrews on 9/10/2021. (nms)
September 3, 2021 Opinion or Order Filing 129 STIPULATION TO EXTEND TIME for Plaintiffs to file public versions of its Letter Brief in opposition and supporting documents to September 10, 2021 - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
September 3, 2021 Opinion or Order Filing 128 ORDER: Defendant's motion to strike Paragraphs 41, 46-62, and 74 from the Opening Expert Report of Dr. David Taft (D.I. #123 ) is DENIED. Signed by Judge Richard G. Andrews on 9/3/2021. (lak)
September 3, 2021 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 9/3/2021. Counsel for Plaintiffs: K. Jacobs, C. Clark. Counsel for Defendant: D. Fry. The transcript of the discovery conference will serve as a memorialization of the Court's ruling. (Court Reporter Heather Triozzi.) (lak)
September 3, 2021 Opinion or Order SO ORDERED, re #129 STIPULATION and Proposed Order to Extend Time for to file public version of to September 10, 2021. Signed by Judge Richard G. Andrews on 9/3/2021. (nms)
September 2, 2021 Opinion or Order Remark: The public may access the hearing scheduled for 9/3/2021, at 11:00 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 687712269#. The dial-in information provides listening capabilities only. (lak)
September 1, 2021 Opinion or Order Filing 127 REDACTED VERSION of #123 Letter, by Norwich Pharmaceuticals Inc.. (Fry, David)
August 27, 2021 Opinion or Order Filing 126 PROPOSED ORDER re #125 Letter by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Jacobs, Karen)
August 27, 2021 Opinion or Order Filing 125 [SEALED] Letter to The Honorable Richard G. Andrews, from Karen Jacobs, regarding opposition to Defendant's Motion to Strike (D.I. #123 ). (Attachments: #1 Exhibits A-F)(Jacobs, Karen) Modified on 8/30/2021 (nms).
August 26, 2021 Opinion or Order CORRECTING ENTRY: D.I. 124 has been unsealed. There is nothing on the face of the filing indicating that it is intended to be sealed. (nms)
August 25, 2021 Opinion or Order Filing 124 Proposed Order to #123 Letter, by Norwich Pharmaceuticals Inc.. (Fry, David) Modified on 8/25/2021 (nms). Modified on 8/26/2021 (nms).
August 25, 2021 Opinion or Order Filing 123 [SEALED] Letter to The Honorable Richard G. Andrews from David M. Fry regarding Motion to Strike. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Fry, David)
August 24, 2021 Opinion or Order Filing 122 ORAL ORDER: The parties have advised that a discovery dispute has arisen that require judicial attention. The Court will hold a discovery conference on 9/3/2021, at 11:00 AM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. The conference will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 8/27/2021. Ordered by Judge Richard G. Andrews on 8/24/2021. (nms)
August 4, 2021 Opinion or Order Filing 121 REDACTED VERSION of #115 Stipulation by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
August 4, 2021 Opinion or Order Filing 120 REDACTED VERSION of #114 Stipulation by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
August 4, 2021 Opinion or Order Filing 119 NOTICE OF SERVICE of (1) Expert Report of David Taft, Ph.D., (2) Expert Report of Philip Schoenfeld, M.D., (3) Expert Report of Robert Brown, M.D., M.P.H., and (4) Expert Report of Allan S. Myerson, Ph.D. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Jacobs, Karen)
August 3, 2021 Opinion or Order Filing 118 NOTICE OF SERVICE of 1. Opening Expert Report of Richard F. Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 3. Opening Expert Report of Carl L. Berg, M.D. Regarding the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening Expert Report of Albert Harary, M.D. Regarding Invalidity filed by Norwich Pharmaceuticals Inc..(Fry, David)
July 29, 2021 Opinion or Order Filing 117 [SEALED] ORDER Granting #115 Stipulation and [Proposed] Order Regarding Certain Uncontested Facts. Signed by Judge Richard G. Andrews on 7/29/2021.This order has been emailed to local counsel. (nms)
July 29, 2021 Opinion or Order Filing 116 [SEALED] ORDERED Granting #114 Sealed Stipulation and Proposed Order Regarding Certain Asserted Claim Limitations. Signed by Judge Richard G. Andrews on 7/29/2021.This order has been emailed to local counsel. (nms)
July 28, 2021 Opinion or Order Filing 115 [SEALED] STIPULATION and [Proposed] Order Regarding Certain Uncontested Facts by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
July 28, 2021 Opinion or Order Filing 114 [SEALED] STIPULATION and [Proposed] Order Regarding Certain Asserted Claim Limitations by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
July 21, 2021 Opinion or Order Filing 113 STIPULATION TO EXTEND TIME of the Deadlines for (1) Opening Expert Reports (2) Rebuttal Expert Reports (3) Reply Expert Reports to (1) August 2, 2021 (2) September 27, 2021 (3) October 18, 2021 - filed by Norwich Pharmaceuticals Inc.. (Fry, David)
July 21, 2021 Opinion or Order SO ORDERED, re #113 STIPULATION TO EXTEND TIME of the Deadlines for (1) Opening Expert Reports (2) Rebuttal Expert Reports (3) Reply Expert Reports to (1) August 2, 2021 (2) September 27, 2021 (3) October 18, 2021. Signed by Judge Richard G. Andrews on 7/21/2021. (nms)
June 30, 2021 Opinion or Order Filing 112 ORAL ORDER Setting Mediation Conferences: A Telephone Conference is set for 12/13/2021 at 09:30 AM before Judge Mary Pat Thynge to discuss case status and prospects for mediation. Counsel for Defendants. Ordered by Judge Mary Pat Thynge on 6/30/2021. (Taylor, Daniel)
June 28, 2021 Opinion or Order Filing 111 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 9-10) filed by Norwich Pharmaceuticals Inc..(Fry, David)
June 25, 2021 Opinion or Order Filing 110 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendant's Third Set of Interrogatories (Nos. 8-16) and (2) Plaintiffs' Second Supplemental Responses and Objections to Defendant's Interrogatory Nos. 1 and 5 and First Supplemental Responses and Objections to Defendant's Interrogatory No. 4 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
June 22, 2021 Opinion or Order Filing 109 NOTICE OF SERVICE of Defendant's Notice of Deposition of Robert Spurr Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
June 22, 2021 Opinion or Order Filing 108 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Final Invalidity Contentions filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
June 18, 2021 Opinion or Order Filing 107 NOTICE OF SERVICE of (1) Defendant Norwich Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-42) (2) Defendant Norwich Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 12-20) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
June 17, 2021 Opinion or Order Filing 106 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Second Set of Requests for Production (Nos. 38-54) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
June 4, 2021 Opinion or Order Filing 105 NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions Against Norwich Pharmaceuticals, Inc. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
June 3, 2021 Opinion or Order Filing 104 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
June 1, 2021 Opinion or Order Filing 103 MOTION for Pro Hac Vice Appearance of Attorney Daniel A. Apgar, Alexis M. McJoynt, and Becky E. Steephenson - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
June 1, 2021 Opinion or Order SO ORDERED, re #103 MOTION for Pro Hac Vice Appearance of Attorney Daniel A. Apgar, Alexis M. McJoynt, and Becky E. Steephenson, filed by Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., AlfaSigma S.p.A.. Signed by Judge Richard G. Andrews on 6/1/2021. (nms)
May 27, 2021 Opinion or Order Filing 102 NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc.'s Third Set of Interrogatories to Plaintiffs (Nos. 8-16) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
May 25, 2021 Opinion or Order Filing 101 NOTICE to Take Deposition of Jyoti Sachdeva on June 8, 2021 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
May 25, 2021 Opinion or Order Filing 100 NOTICE OF SERVICE of (1) Notice of Subpoena Duces Tecum of Mark Pimentel, M.D. (2) Notice of Subpoena Ad Testificandum of Mark Pimentel, M.D. (3) Notice of Subpoena Duces Tecum of Herbert L. DuPont, M.D. (4) Notice of Subpoena Ad Testificandum of Herbert L. DuPont, M.D. filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
May 24, 2021 Opinion or Order Filing 99 REDACTED VERSION of #94 Notice to Take Deposition by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
May 19, 2021 Opinion or Order Filing 98 NOTICE OF SERVICE of (1) Norwich Pharmaceuticals, Inc.'s First Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Plaintiffs Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Bausch Health Ireland Ltd., and Alfasigma S.P.A. (2) Norwich Pharmaceutical Inc.'s Second Set of Requests for Production (Nos. 38-54) to Plaintiffs filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
May 18, 2021 Opinion or Order Filing 97 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admission (Nos. 1-42) and (2) Plaintiffs' Third Set of Interrogatories (Nos. 12-20) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
May 18, 2021 Opinion or Order Filing 96 MOTION for Pro Hac Vice Appearance of Attorney Rebecca L. Clegg - filed by Norwich Pharmaceuticals Inc.. (Keller, Karen)
May 18, 2021 Opinion or Order SO ORDERED, re #96 MOTION for Pro Hac Vice Appearance of Attorney Rebecca L. Clegg, filed by Norwich Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/18/2021. (nms)
May 18, 2021 Opinion or Order Pro Hac Vice Attorney Rebecca L. Clegg for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
May 14, 2021 Opinion or Order Filing 95 NOTICE OF SERVICE of (1) Defendants' Notice of Deposition of Dario Braga Pursuant to Federal Rule of Civil Procedure 30(B)(1) (2) Defendants' Notice of Deposition of Lorin Johnson Pursuant to Federal Rule of Civil Procedure 30(B)(1) (3) Defendants' Notice of Deposition of Giuseppe Claudio Viscomi Pursuant to Federal Rule of Civil Procedure 30(B)(1) (4) Subpoena for Testimony and Documents to William Forbes (5) Subpoena for Testimony and Documents to Enoch Bortey filed by Norwich Pharmaceuticals Inc..(Fry, David)
May 14, 2021 Opinion or Order Filing 94 [SEALED] NOTICE to Take Deposition of Defendant Norwich Pharmaceuticals, Inc. on June 21, 2021 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
May 14, 2021 Opinion or Order Filing 93 NOTICE to Take Deposition of James Baker on June 17, 2021 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
May 14, 2021 Opinion or Order Filing 92 NOTICE to Take Deposition of Paul Fackler on June 16, 2021 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
May 14, 2021 Opinion or Order Filing 91 NOTICE to Take Deposition of Zhen Mei on June 8, 2021 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
April 29, 2021 Opinion or Order Filing 90 MEMORANDUM OPINION providing claim construction for various terms in U.S. Patent Nos. 7,045,620 (the 620 Patent), 7,902,206 (the 206 Patent), 7,915,275 (the 275 Patent), 8,642,573 (the 573 Patent), 9,629,828 (the 9,828 Patent), and 10,314,828 (the 4,828 Patent). Signed by Judge Richard G. Andrews on 4/29/2021. (nms)
April 27, 2021 Opinion or Order Filing 89 Joint Letter to The Honorable Richard G. Andrews, from Cameron P. Clark, regarding resolution of claim construction term. (Clark, Cameron) Modified on 4/28/2021 (nms).
April 22, 2021 Opinion or Order Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 4/22/2021. Counsel for Plaintiffs: K. Jacobs. Counsel for Defendant: K. Keller. The parties are directed to submit a letter on or before 4/28/2021 stating dispute resolution. (Court Reporter Heather Triozzi.) (lak)
April 21, 2021 Opinion or Order Remark: The public may access the hearing scheduled for 4/22/2021, at 9:00 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 137142655#. The dial-in information provides listening capabilities only. (lak)
April 21, 2021 Opinion or Order CORRECTING ENTRY: The pdf for Exhibit M found at D.I. #84 has been replaced with a more complete version per counsel's request. (nms)
April 6, 2021 Opinion or Order Filing 88 REDACTED VERSION of #84 Appendix, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit I, #2 Exhibit J, #3 Exhibit K, #4 Exhibit L, #5 Exhibit M, #6 Exhibit N, #7 Exhibit O, #8 Exhibit P, #9 Exhibit Q, #10 Exhibit R, #11 Exhibit S, #12 Exhibit T, #13 Exhibit U, #14 Exhibit V, #15 Exhibit W, #16 Exhibit X, #17 Exhibit Y)(Clark, Cameron) Modified on 4/7/2021 (nms).
April 6, 2021 Opinion or Order Filing 87 REDACTED VERSION of #82 Joint Claim Construction Brief, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 4/7/2021 (nms).
March 31, 2021 Opinion or Order Filing 86 SO ORDERED, Granting #85 Joint Motion for Claim Construction. Signed by Judge Richard G. Andrews on 3/31/2021. (nms)
March 30, 2021 Opinion or Order Filing 85 Joint Motion for Claim Construction - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/31/2021 (nms).
March 30, 2021 Opinion or Order Filing 84 [SEALED] Joint Appendix, Volume 2 of 2 re #82 Joint Claim Construction Brief, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit I, #2 Exhibit J, #3 Exhibit K, #4 Exhibit L, #5 Exhibit M, #6 Exhibit N, #7 Exhibit O, #8 Exhibit P, #9 Exhibit Q, #10 Exhibit R, #11 Exhibit S, #12 Exhibit T, #13 Exhibit U, #14 Exhibit V, #15 Exhibit W, #16 Exhibit X, #17 Exhibit Y)(Clark, Cameron) Modified on 3/31/2021 (nms). (Attachment 5 replaced on 4/21/2021) (nms).
March 30, 2021 Opinion or Order Filing 83 Joint Appendix, Volume 1 of 2 re #82 Joint Claim Construction Brief, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit A part 1, #2 Exhibit A part 2, #3 Exhibit A part 3, #4 Exhibit B, #5 Exhibit C, #6 Exhibit D, #7 Exhibit E, #8 Exhibit F, #9 Exhibit G, #10 Exhibit H)(Clark, Cameron) Modified on 3/31/2021 (nms).
March 30, 2021 Opinion or Order Filing 82 [SEALED] Joint Claim Construction Brief, filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 3/31/2021 (nms).
March 12, 2021 Opinion or Order Filing 81 ORAL ORDER: The Markman hearing scheduled for 4/22/2021, will be held using Teams. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 4/15/2021. Ordered by Judge Richard G. Andrews on 3/12/2021. (nms)
March 4, 2021 Opinion or Order Filing 80 NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
February 18, 2021 Opinion or Order Filing 79 REDACTED VERSION of #77 Unopposed Motion for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
February 16, 2021 Opinion or Order Filing 78 [SEALED] Letter of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad in Civil or Commercial Matters to Obtain Evidence from C.F.M. Group. Signed by Judge Richard G. Andrews on 2/16/2021.*This order is available for pickup at Clerks Office by local counsel. (nms)
February 11, 2021 Opinion or Order Filing 77 [SEALED] Unopposed Motion for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit A)(Clark, Cameron) Modified on 2/11/2021 (nms).
February 10, 2021 Opinion or Order Filing 76 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about: February 14, 2020 for Patent Numbers 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,271,968; 9,421,195; 9,629,828; 10,314,828; 10,335,397; and 10,456,384; On or about October 6, 2020 for Patent Numbers 10,703,763 and 10,709,694; On or about November 16, 2020 for Patent Number 10,765,667.. Date of Expiration of Patent: June 19, 2024 for Patent Nos. 7,045,620; 7,612,199; 7,902,206; 8,158,644; 8,158,781; 8,835,452; 8,853,231; June 1, 2025 for Patent No. 7,906,542; February 23, 2025 for Patent No. 7,915,275; February 27, 2026 for Patent Nos. 8,518,949; 8,741,904; 9,271,968; 10,703,763; September 2, 2027 for Patent No. 8,193,196; February 26, 2029 for Patent Nos. 10,456,384; 10,765,667; July 18, 2029 for Patent No. 8,309,569; July 24, 2029 for Patent Nos. 8,829,017; 8,946,252; 9,421,195; 9,629,828; 10,314,828; 10,335,397; 10,709,694; October 2, 2029 for Patent Nos. 8,642,573; 8,969,398..Thirty Month Stay Deadline: 8/14/2022. (Clark, Cameron)
February 10, 2021 Opinion or Order Filing 75 STIPULATION TO EXTEND TIME to substantially complete document production to March 15, 2021 - filed by Norwich Pharmaceuticals Inc.. (Fry, David)
February 10, 2021 Opinion or Order SO ORDERED, re #75 STIPULATION TO EXTEND TIME to substantially complete document production to March 15, 2021. Signed by Judge Richard G. Andrews on 2/10/2021. (nms)
February 3, 2021 Opinion or Order Filing 74 ORAL ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 6/28/2021 at 9:30 AM Eastern Time with Judge Mary Pat Thynge to discuss the status of the case and mediation. Ordered by Judge Mary Pat Thynge on 2/3/21. (cak)
January 29, 2021 Opinion or Order Filing 73 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Defendant's Interrogatory Nos. 1, 2, and 5 filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
January 14, 2021 Opinion or Order Filing 72 NOTICE OF SERVICE of (1) Plaintiffs' Opening Claim Construction Brief and (2) Declaration of Allan Myerson, Ph.D. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
January 5, 2021 Opinion or Order Filing 71 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Second Set of Interrogatories (Nos. 6-7) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
December 23, 2020 Opinion or Order Filing 70 Joint Claim Construction Chart, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibits C-I, #2 Exhibit J, #3 Exhibit K)(Clark, Cameron) Modified on 12/28/2020 (nms).
December 23, 2020 Opinion or Order Filing 69 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Initial Invalidity Contentions filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
December 21, 2020 Opinion or Order Filing 68 ANSWER to #65 Answer to Amended Complaint,, Counterclaim, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
December 21, 2020 Opinion or Order Filing 67 STIPULATION TO EXTEND TIME for the parties to file a Joint Claim Construction Chart to December 23, 2020 - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
December 21, 2020 Opinion or Order SO ORDERED, re #67 STIPULATION and Proposed Order to Extend Time to file a Joint Claim Construction Chart to December 23, 2020. Signed by Judge Richard G. Andrews on 12/21/2020. (nms)
December 8, 2020 Opinion or Order Filing 66 NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions with Citations to Intrinsic Evidence filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
November 30, 2020 Opinion or Order Filing 65 ANSWER to #59 Amended Complaint, Affirmative Defenses, and COUNTERCLAIMS against AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd., by Norwich Pharmaceuticals Inc..(Keller, Karen) Modified on 12/1/2020 (nms).
November 30, 2020 Opinion or Order Filing 64 NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions for U.S. Patent Nos. 10,765,667 and 10,709,694 Against Norwich Pharmaceuticals, Inc. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
November 24, 2020 Opinion or Order Filing 63 NOTICE OF SERVICE of Plaintiffs' List of Claim Terms filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Jacobs, Karen)
November 20, 2020 Opinion or Order Filing 62 NOTICE OF SERVICE of Plaintiffs' Identification of New Asserted Claims Against Norwich Pharmaceuticals, Inc. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
November 16, 2020 Opinion or Order Filing 61 NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc's Second Set of Interrogatories to Plaintiffs (Nos. 6-7) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
November 13, 2020 Opinion or Order Filing 60 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 10,703,763 B2; 10,709,694 B2; 10,765,667 B2. (Clark, Cameron) Modified on 11/16/2020 (nms).
November 13, 2020 Opinion or Order Filing 59 First Amended Complaint for Patent Infringement against Norwich Pharmaceuticals Inc. - filed by Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd., AlfaSigma S.p.A., Salix Pharmaceuticals, Inc.. (Attachments: #1 Exhibits A-AA)(Clark, Cameron) Modified on 11/13/2020 (nms).
November 12, 2020 Opinion or Order Filing 58 SO ORDERED Granting #57 Stipulation and Proposed Order to File First Amended Complaint and to Amend the Scheduling Order. Signed by Judge Richard G. Andrews on 11/12/2020. (nms)
November 11, 2020 Opinion or Order Filing 57 STIPULATION and Proposed Order to File First Amended Complaint and to Amend the Scheduling Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibits A-B)(Clark, Cameron) Modified on 11/12/2020 (nms).
November 10, 2020 Opinion or Order Filing 56 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 9-11) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
October 30, 2020 Opinion or Order Filing 55 REDACTED VERSION of #50 Unopposed Motion for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibit A-B)(Clark, Cameron)
October 30, 2020 Opinion or Order Filing 54 REDACTED VERSION of #49 MOTION for Issuance of Letters Rogatory by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
October 27, 2020 Opinion or Order Filing 53 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Inc.'s Preliminary Invalidity Contentions filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
October 27, 2020 Opinion or Order REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI #49 and #50 . (nms)
October 19, 2020 Opinion or Order Filing 52 [SEALED] Letter of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad in Civil or Commercial Matters to Obtain Evidence from C.F.M. Group (see motion at D.I. #50 ). Signed by Judge Richard G. Andrews on 10/19/2020.*This order is available for pickup at Clerks Office by local counsel. (nms)
October 19, 2020 Opinion or Order Filing 51 [SEALED] Request for International Judicial Assistance (A Letter Rogatory) to Obtain Evidence From Clarochem Ireland Limited (see motion at D.I. #49 ). Signed by Judge Richard G. Andrews on 10/19/2020.*This order is available for pickup at Clerks Office by local counsel. (nms)
October 16, 2020 Opinion or Order Filing 50 [SEALED] Unopposed Motion for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Exhibits A-B)(Clark, Cameron) Modified on 10/16/2020 (nms).
October 16, 2020 Opinion or Order Filing 49 [SEALED] MOTION for Issuance of Letters Rogatory - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
October 2, 2020 Opinion or Order Filing 48 REDACTED VERSION of #47 Notice (Other) by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
September 25, 2020 Opinion or Order Filing 47 [SEALED] NOTICE of Subpoena to MSN Pharmaceuticals Inc. by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. (Jacobs, Karen)
September 25, 2020 Opinion or Order CORRECTING ENTRY: The Notice of Subpoena filed at D.I. 45 has been removed from the docket per counsel's request. The notice will be refiled under seal. (nms)
September 23, 2020 Opinion or Order Filing 46 NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories (Nos. 9-11) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
September 8, 2020 Opinion or Order Filing 44 NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Norwich Pharmaceuticals, Inc. filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
September 1, 2020 Opinion or Order Filing 43 NOTICE OF SERVICE of 1.) Defendant Norwich Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8) 2.) Defendant's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 5-107) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
August 31, 2020 Opinion or Order Filing 42 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendant's First Set of Interrogatories (Nos. 1-5) and (2) Plaintiffs' Responses and Objections to Defendant's First Set of Requests for Production (Nos. 1-37) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
August 18, 2020 Opinion or Order Filing 41 ORAL ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 1/11/2021 at 9:30 AM Eastern Time with Judge Mary Pat Thynge to discuss the status of the case in relation to mediation. Ordered by Judge Mary Pat Thynge on 8/18/20. (cak)
August 7, 2020 Opinion or Order Filing 40 NOTICE OF SERVICE of Plaintiffs' Supplemental Rule 26(a)(1) Initial Disclosures filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
July 30, 2020 Opinion or Order Filing 39 NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
July 30, 2020 Opinion or Order Filing 38 NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-4) filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
July 27, 2020 Opinion or Order Filing 37 SO ORDERED Granting #35 Stipulated Protective Order. Signed by Judge Richard G. Andrews on 7/27/2020. (nms)
July 24, 2020 Opinion or Order Filing 36 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 5-107) and (2) Plaintiffs' First Set of Interrogatories (Nos. 1-8) filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
July 24, 2020 Opinion or Order Filing 35 PROPOSED Stipulated Protective Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 7/24/2020 (nms).
July 24, 2020 Opinion or Order Filing 34 NOTICE OF SERVICE of (1.) Norwich Pharmaceutical Inc.'s First Set of Requests for Production (Nos. 1-37) to Plaintiffs (2.) Norwich Pharmaceuticals, Inc.'s First Set of Interrogatories to Plaintiffs (Nos. 1-5) filed by Norwich Pharmaceuticals Inc..(Fry, David)
July 9, 2020 Opinion or Order SO ORDERED, re #33 STIPULATION and Proposed Order to extend time for the parties to submit a proposed Protective Order to July 24, 2020. Signed by Judge Richard G. Andrews on 7/9/2020. (nms)
July 8, 2020 Opinion or Order Filing 33 STIPULATION and Proposed Order - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 7/9/2020 (nms).
July 8, 2020 Opinion or Order Filing 32 SO ORDERED Granting #31 Stipulation and Proposed Order Dismissing Without Prejudice Defendant Alvogen PB Research and Development (*Party Alvogen PB Research And Development LLC terminated). Signed by Judge Richard G. Andrews on 7/8/2020. (nms)
July 7, 2020 Opinion or Order Filing 31 STIPULATION and Proposed Order Dismissing Without Prejudice Defendant Alvogen PB Research and Development LLC, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron) Modified on 7/8/2020 (nms).
July 1, 2020 Opinion or Order Filing 30 NOTICE OF SERVICE of Defendant Norwich Pharmaceuticals, Incs Rule 26(a)(1) Initial Disclosures filed by Norwich Pharmaceuticals Inc..(Keller, Karen)
July 1, 2020 Opinion or Order SO ORDERED, re #29 STIPULATION TO EXTEND TIME for Alvogen to provide its Rule 26(a)(1) disclosures to July 14, 2020. Signed by Judge Richard G. Andrews on 7/1/2020. (nms)
June 30, 2020 Opinion or Order Filing 29 STIPULATION TO EXTEND TIME for Alvogen to provide its Rule 26(a)(1) disclosures to July 14, 2020 - filed by Alvogen PB Research And Development LLC. (Keller, Karen)
June 30, 2020 Opinion or Order Filing 28 NOTICE OF SERVICE of (1) Plaintiffs' Initial Discovery Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
June 30, 2020 Opinion or Order Pro Hac Vice Attorney Matthew S. Murphy for Alvogen PB Research And Development LLC, for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
June 30, 2020 Opinion or Order Pro Hac Vice Attorney Matthew J. Becker for Alvogen PB Research And Development LLC, for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
June 30, 2020 Opinion or Order Pro Hac Vice Attorney Stacie L. Ropka for Alvogen PB Research And Development LLC, for Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
June 29, 2020 Opinion or Order Filing 27 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron)
June 29, 2020 Opinion or Order Filing 26 ORDER Setting Teleconference: A Telephone Conference is set for 8/4/2020 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Counsel for plaintiff shall initiate the call. Signed by Judge Mary Pat Thynge on 6/29/20. (cak)
June 22, 2020 Opinion or Order Filing 25 ANSWER to #14 Answer to Complaint, and Counterclaims, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd..(Clark, Cameron) Modified on 6/23/2020 (nms).
June 16, 2020 Opinion or Order CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
June 16, 2020 Opinion or Order SO ORDERED, re #22 MOTION for Pro Hac Vice Appearance of Attorney Chad A. Landmon, filed by Norwich Pharmaceuticals Inc., Alvogen PB Research And Development LLC. Signed by Judge Richard G. Andrews on 6/16/2020. (nms)
June 16, 2020 Opinion or Order Pro Hac Vice Attorney Chad A. Landmon for Alvogen PB Research And Development LLC and Norwich Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
June 15, 2020 Opinion or Order Filing 24 ORAL ORDER: The Rule 16(b)Scheduling Conference set for 6/16/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 6/15/2020. (crb)
June 15, 2020 Opinion or Order Filing 23 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Discovery due by 6/25/2021. Fact Discovery completed by 6/25/2021. Joint Claim Construction Brief due by 3/30/2021. A Markman Hearing is set for 4/22/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/4/2022, at 9:00 AM in Courtroom 6A. A Bench Trial is set for 3/21/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/15/2020. (crb) Modified on 6/16/2020 (nms).
June 15, 2020 Opinion or Order Filing 22 MOTION for Pro Hac Vice Appearance of Attorney Chad A. Landmon - filed by Alvogen PB Research And Development LLC, Norwich Pharmaceuticals Inc.. (Keller, Karen)
June 15, 2020 Opinion or Order Filing 21 PROPOSED Scheduling Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Letter)(Jacobs, Karen) Modified on 6/16/2020 (nms).
June 12, 2020 Opinion or Order Filing 20 PROPOSED Scheduling Order, by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: #1 Letter)(Jacobs, Karen) Modified on 6/12/2020 (nms).
June 4, 2020 Opinion or Order SO ORDERED, re #19 MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Stacie L. Ropka, and Matthew S. Murphy, filed by Norwich Pharmaceuticals Inc., Alvogen PB Research And Development LLC. Signed by Judge Richard G. Andrews on 6/4/2020. (nms)
June 3, 2020 Opinion or Order Filing 19 MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Stacie L. Ropka, and Matthew S. Murphy - filed by Alvogen PB Research And Development LLC, Norwich Pharmaceuticals Inc.. (Keller, Karen)
June 3, 2020 Opinion or Order Filing 18 ORAL ORDER: The Motion for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Stacie L. Ropka, and Matthew S. Murphy (D.I. #17 ) is DENIED without prejudice to renew. Certifications by counsel need to be dated as to the day they were signed. Ordered by Judge Richard G. Andrews on 6/3/2020. (nms)
June 3, 2020 Opinion or Order Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Stacie L. Ropka, and Matthew S. Murphy - filed by Alvogen PB Research And Development LLC, Norwich Pharmaceuticals Inc.. (Keller, Karen)
June 2, 2020 Opinion or Order Filing 16 Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 6/16/2020, at 10:00 AM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 6/2/2020. (nms) Modified on 6/2/2020 (nms).
June 1, 2020 Opinion or Order Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Group, Inc., Other Affiliate Alvogen Lux Holdings S.a.r.l., Other Affiliate Alvogen Holdings (Hungary) LLC, Other Affiliate Alvogen Pharma Ltd. Malta, Other Affiliate Alvogen Pharma US, Inc. for Norwich Pharmaceuticals, Inc. filed by Norwich Pharmaceuticals, Inc.. (Keller, Karen) Modified on 6/2/2020 (nms).
June 1, 2020 Opinion or Order Filing 14 ANSWER to #1 Complaint, and COUNTERCLAIMS against Norwich Pharmaceuticals, Inc., by Norwich Pharmaceuticals, Inc..(Keller, Karen) Modified on 6/2/2020 (nms).
June 1, 2020 Opinion or Order Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Group, Inc., Other Affiliate Alvogen Lux Holdings S.a.r.l., Other Affiliate Alvogen Pharma US, Inc, Other Affiliate Alvogen Holdings (Hungary) LLC, Other Affiliate Alvogen Pharma Ltd. Malta for Alvogen PB Research And Development LLC filed by Alvogen PB Research And Development LLC. (Keller, Karen)
June 1, 2020 Opinion or Order Filing 12 ANSWER to #1 Complaint, and Affirmative Defenses, by Alvogen PB Research And Development LLC.(Keller, Karen) Modified on 6/2/2020 (nms).
April 13, 2020 Opinion or Order Filing 11 WAIVER OF SERVICE returned executed by Salix Pharmaceuticals, Ltd., Bausch Health Ireland Ltd., AlfaSigma S.p.A., Salix Pharmaceuticals, Inc.: For Norwich Pharmaceuticals, Inc. waiver sent on 4/1/2020, answer due 6/1/2020. (Clark, Cameron) Modified on 6/2/2020 (nms).
April 13, 2020 Opinion or Order Filing 10 WAIVER OF SERVICE returned executed by Salix Pharmaceuticals, Ltd., Bausch Health Ireland Ltd., AlfaSigma S.p.A., Salix Pharmaceuticals, Inc.: For Alvogen PB Research And Development LLC waiver sent on 4/1/2020, answer due 6/1/2020. (Clark, Cameron)
April 2, 2020 Opinion or Order Filing 9 Letter to John A. Cerino, Clerk of the Court from Karen Jacobs regarding Notice of Related Case. (Jacobs, Karen)
April 2, 2020 Opinion or Order Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
April 1, 2020 Opinion or Order SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Scott K. Reed, Steven C. Kline and Shannon K. Clark filed by Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., AlfaSigma S.p.A. Signed by Judge Colm F. Connolly on 4/1/2020. (nmf)
April 1, 2020 Opinion or Order Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
March 27, 2020 Opinion or Order Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Scott K. Reed, Steven C. Kline and Shannon K. Clark - filed by AlfaSigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Clark, Cameron)
March 26, 2020 Opinion or Order Filing 7 Remark: Please complete the top portion of the form and print out for use/service (myr)
March 26, 2020 Opinion or Order Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Marino Golinelli & C. S.A.P.A. for AlfaSigma S.p.A. filed by AlfaSigma S.p.A. (myr)
March 26, 2020 Opinion or Order Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Bausch Health Companies Inc. for Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. filed by Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (myr)
March 26, 2020 Opinion or Order Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620 ;7,612,199 ;7,902,206 ;7,906,542 ;7,915,275. (myr)
March 26, 2020 Opinion or Order Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 14, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/14/2022. (myr)
March 26, 2020 Opinion or Order Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
March 26, 2020 Opinion or Order Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Alvogen PB Research And Development LLC, Norwich Pharmaceticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2886523.) - filed by Salix Pharmaceuticals, Ltd., Bausch Health Ireland Ltd., AlfaSigma S.p.A., Salix Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-X, #2 Civil Cover Sheet)(myr)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alvogen PB Research And Development LLC
Represented By: Karen Elizabeth Keller
Represented By: Chad A. Landmon
Represented By: Matthew J. Becker
Represented By: Matthew S. Murphy
Represented By: Stacie L. Ropka
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Norwich Pharmaceticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Norwich Pharmaceuticals Inc.
Represented By: Nathan Roger Hoeschen
Represented By: Aziz Burgy
Represented By: Chad A. Landmon
Represented By: David M. Fry
Represented By: Matthew J. Becker
Represented By: Matthew S. Murphy
Represented By: Rebecca L. Clegg
Represented By: Ricardo S. Camposanto
Represented By: Stacie L. Ropka
Represented By: Karen Elizabeth Keller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Salix Pharmaceuticals, Inc.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Cameron Paul Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Bausch Health Ireland Ltd.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Cameron Paul Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Salix Pharmaceuticals, Ltd.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Cameron Paul Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: AlfaSigma S.p.A.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Cameron Paul Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?